1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lohmeyer, M; Workman, P | 1 |
| Erickson, KL | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Dietary fat, breast cancer, and nonspecific immunity.
Topics: Animals; Breast Neoplasms; Dietary Fats; Female; Humans; Immunity; Inflammation; Mammary Neoplasms, Experimental; Platelet Activating Factor; Tumor Cells, Cultured | 1998 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Cycle; Cell Division; Cell Membrane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Experimental; Mice; Phospholipid Ethers; Platelet Activating Factor; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 1995 |